| CAR T-Cell-Based gene therapy for cancers: new perspectives, challenges, and clinical developments MP Jogalekar, RL Rajendran, F Khan, C Dmello, P Gangadaran, BC Ahn Frontiers in immunology 13, 925985, 2022 | 84 | 2022 |
| A mini-review on the effects of COVID-19 on younger individuals M Manivannan, MP Jogalekar, MS Kavitha, BAV Maran, P Gangadaran Experimental biology and medicine 246 (3), 293-297, 2021 | 64 | 2021 |
| Tumor microenvironment signaling and therapeutics in cancer progression A Goenka, F Khan, B Verma, P Sinha, CC Dmello, MP Jogalekar, ... Cancer Communications 43 (5), 525-561, 2023 | 56 | 2023 |
| Novel 2019 coronavirus: Genome structure, clinical trials, and outstanding questions MP Jogalekar, A Veerabathini, P Gangadaran Experimental Biology and Medicine 245 (11), 964-969, 2020 | 47 | 2020 |
| An update on the effectiveness of probiotics in the prevention and treatment of cancer V Sankarapandian, BA Venmathi Maran, RL Rajendran, MP Jogalekar, ... Life 12 (1), 59, 2022 | 37 | 2022 |
| SARS-CoV-2 variants: A double-edged sword? MP Jogalekar, A Veerabathini, P Gangadaran Experimental Biology and Medicine 246 (15), 1721-1726, 2021 | 35 | 2021 |
| Urine biomarkers of kidney tubule health, injury, and inflammation are associated with progression of CKD in children JH Greenberg, AG Abraham, Y Xu, JR Schelling, HI Feldman, ... Journal of the American Society of Nephrology 32 (10), 2664-2677, 2021 | 28 | 2021 |
| Convalescent serum-derived exosomes: Attractive niche as COVID-19 diagnostic tool and vehicle for mRNA delivery A Krishnan, P Gangadaran, VP Chavda, MP Jogalekar, R Muthusamy, ... Experimental Biology and Medicine 247 (14), 1244-1252, 2022 | 23 | 2022 |
| Biomarkers of kidney tubule disease and risk of end-stage kidney disease in persons with diabetes and CKD JG Amatruda, R Katz, MJ Sarnak, OM Gutierrez, JH Greenberg, ... Kidney International Reports 7 (7), 1514-1523, 2022 | 15 | 2022 |
| Prebiotic Potential and Value-Added Products Derived from Spirulina laxissima SV001—A Step towards Healthy Living V Sankarapandian, K Nitharsan, K Parangusadoss, P Gangadaran, ... BioTech 11 (2), 13, 2022 | 14 | 2022 |
| Morphometric analysis of a triple negative breast cancer cell line in hydrogel and monolayer culture environments MP Jogalekar, EE Serrano PeerJ 6, e4340, 2018 | 14 | 2018 |
| COVID-19 and diabetes: What do we know so far? P Gangadaran, H Padinjarathil, SHS Rajendran, MP Jogalekar, CM Hong, ... Experimental Biology and Medicine 247 (15), 1330-1334, 2022 | 13 | 2022 |
| Recent developments in autophagy-targeted therapies in cancer MP Jogalekar, A Veerabathini, P Gangadaran Experimental Biology and Medicine 246 (2), 207-212, 2021 | 13 | 2021 |
| Plasma biomarkers as risk factors for incident CKD MJ Sarnak, R Katz, JH Ix, PL Kimmel, JV Bonventre, J Schelling, ... Kidney International Reports 7 (7), 1493-1501, 2022 | 11 | 2022 |
| Noninvasive in vivo cell tracking using molecular imaging: a useful tool for developing mesenchymal stem cell-based cancer treatment RL Rajendran, MP Jogalekar, P Gangadaran, BC Ahn World Journal of Stem Cells 12 (12), 1492, 2020 | 10 | 2020 |
| Hydrogel environment supports cell culture expansion of a grade IV astrocytoma MP Jogalekar, LG Cooper, EE Serrano Neurochemical research 42, 2610-2624, 2017 | 7 | 2017 |
| A single inactivating amino acid change in the SARS-CoV-2 NSP3 Mac1 domain attenuates viral replication in vivo TY Taha, RK Suryawanshi, IP Chen, GJ Correy, M McCavitt-Malvido, ... PLoS Pathogens 19 (8), e1011614, 2023 | 6 | 2023 |
| Application of orthobiologics in Achilles tendinopathy: a review LC Ramires, M Jeyaraman, S Muthu, N Shankar A, GS Santos, ... Life 12 (3), 399, 2022 | 5 | 2022 |
| COVID-19: Antiviral agents and enzyme inhibitors/receptor blockers in development MP Jogalekar, A Veerabathini, AB Patel Experimental Biology and Medicine 246 (13), 1533-1540, 2021 | 4 | 2021 |
| Total RNA Isolation from Separately Established Monolayer and Hydrogel Cultures of Human Glioblastoma Cell Line MP Jogalekar, EE Serrano Bio-protocol 9 (14), e3305, 2019 | 4 | 2019 |
Prakash Gangadaran., M.Sc., PhD.,Professor (Research), Research Director (PI), Kyungpook National University.在 knu.ac.kr 的电子邮件经过验证
